Medinet Co. Ltd. | Cash Flow

Fiscal year is October-September. All values JPY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
341,587.00
1,571,081.00
1,665,121.00
1,634,366.00
2,635,665.00
3,037,893
Depreciation, Depletion & Amortization
211,244.00
195,283.00
278,291.00
356,761.00
320,188.00
193,445
Other Funds
2,924.00
229.00
4,348.00
501,959.00
11,490.00
295,116
Funds from Operations
555,546.00
1,088,363.00
1,400,290.00
1,328,606.00
1,475,394.00
3,139,564
Changes in Working Capital
39,536.00
68,259.00
167,085.00
240,510.00
142,249.00
640,077
Net Operating Cash Flow
516,010.00
1,020,104.00
1,567,375.00
1,088,096.00
1,333,145.00
2,499,487
Capital Expenditures
111,299.00
578,419.00
975,350.00
57,391.00
21,088.00
Purchase/Sale of Investments
626,840.00
373,018.00
1,000.00
285,807.00
-
Net Investing Cash Flow
581,956.00
1,155,834.00
856,760.00
430,269.00
199,714.00
Issuance/Reduction of Debt, Net
21,519.00
27,201.00
48,702.00
59,728.00
649,969.00
Net Financing Cash Flow
3,993,521.00
405,825.00
325,059.00
440,297.00
975,814.00
Net Change in Cash
4,059,467.00
1,770,113.00
2,099,076.00
217,530.00
157,617.00
Free Cash Flow
562,921.00
1,491,972.00
2,426,422.00
1,104,900.00
1,335,618.00
Other Sources
77,200.00
55,447.00
121,950.00
209,502.00
244,794.00
Change in Capital Stock
4,017,964.00
433,255.00
378,109.00
1,933.00
1,637,273.00
Other Uses
10,785.00
1,005,880.00
4,360.00
7,650.00
23,992.00

About Medinet Co.

View Profile
Address
Shin-Yokohama Square Building, 14/F
Yokohama Kanagawa 222
Japan
Employees -
Website http://www.medinet-inc.co.jp
Updated 07/08/2019
MEDINET Co., Ltd. engages in cell processing business. It offers solutions for regenerative medicine and cell therapy value chain through preclinical research, development, manufacturing and commercial launch. It operates through the Cell Processing and Regenerative Medical Products segments.